From sunlight to screen light: lifestyle factors driving the myopia epidemic
Date: 19/05/2026 ()
Venue: https://lms.optometry.org.au/course/view.php?id=992
Provider: OA National Provider
Contact: Optometry Australia Optometry Australia, [E] cpd@optometry.org.au, [P] 96688550
Activity Outline
As myopia prevalence rises globally, lifestyle habits have emerged as modifiable drivers of refractive change. This webinar examines the current evidence linking lifestyle factors—near work, time outdoors, light exposure, diurnal habits and digital behaviours—to myopia development and progression. We will critically analyse the evidence and translate this into practical guidance designed to enhance your care of both pre-myopic and established myopic patients in optometric practice.
The following sponsored presentation will showcase the clinical performance and practical advantages of MyDay® MiSight® 1 day for myopia control. Hear directly from fellow myopia management practitioners as they share their real-world outcomes and key learnings from prescribing MyDay® MiSight® 1 day. These insights will support confident clinical decision-making and effective prescribing in everyday practice.
Learning Objectives
- Discuss some of the latest evidence linking various lifestyle and environmental factors to myopia onset and progression
- Critically analyse patient’s risk profiles in relation to myopia
- Develop a series of evidence-based patient recommendations to help delay myopia onset and slow progression
- Discuss key clinical findings on vision, comfort, handling and fit for MyDay® MiSight® 1 day
- Describe insights from fellow optometrists’ experience of prescribing MyDay® MiSight® 1 day
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| From sunlight to screen light: lifestyle factors driving the myopia epidemic |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1 |
| Name |
|---|
| Real-world Insights on Prescribing MyDay® MiSight®1 day |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |